Rochester Medical (ROCM) Misses Q4 EPS by 1c
Rochester Medical Corporation (NASDAQ: ROCM) reports Q4 EPS of $0.01, 1 cents below the analyst estimate of $0.02. Revenue for the quarter was $9.01 million, which compares to the estimate of $9.57 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
